Sandoz releases generic version of Latisse
PRINCETON, N.J. — Sandoz Inc. has introduced bimatoprost ophthalmic solution 0.03%, an eyelash treatment, in the U.S. market. The Novartis subsidiary said its bimatoprost ophthalmic product is a generic version of Latisse from Allergan. A prescription medicine, bimatoprost ophthalmic solution 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length,
